Follow us on Twitter
twitter icon@FreshPatents


Gastrointestinal Tract patents

      

This page is updated frequently with new Gastrointestinal Tract-related patent applications.




 Treatments for gastrointestinal conditions patent thumbnailTreatments for gastrointestinal conditions
Compounds for the treatment of bacterial and parasitic infections which are hybrid compounds of compounds having antibacterial or antiparasitic activity and compounds that decrease the absorption of the hybrid compound from the gastrointestinal tract. The compounds are preferably for use against c.
St. Jude Children's Research Hospital, Inc.


 Methods and pharmaceutical compositions for treating diseases associated with altered sert activity patent thumbnailMethods and pharmaceutical compositions for treating diseases associated with altered sert activity
The present invention provides, inter alia, methods for treating or ameliorating the effects of a disease associated with altered serotonin transporter molecule (sert) activity in a subject in need thereof. The methods include administering to the subject an effective amount of a 5-ht4 agonist or a pharmaceutically acceptable salt thereof.
The Trustees Of Columbia Univesity In The City Of New York


 Oral pharmaceutical dosage forms of budesonide patent thumbnailOral pharmaceutical dosage forms of budesonide
The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of crohn's disease.. .
Sun Pharmaceutical Industries Ltd.


 Orally administered corticosteroid compositions patent thumbnailOrally administered corticosteroid compositions
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual.
Adare Pharmaceuticals, Inc.


 Antisense treatment of radiation induced diseases in the gastrointestinal tract patent thumbnailAntisense treatment of radiation induced diseases in the gastrointestinal tract
This invention relates to a composition comprising an antisense oligonucleotide for use in treating radiation induced disease of the gastrointestinal tract.. .
Atlantic Pharmaceuticals (holdings) Ltd


 Treatment of gluten intolerance and related conditions patent thumbnailTreatment of gluten intolerance and related conditions
Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as c.
Nepetx, Llc


 Analogs of fexaramine and methods of making and using patent thumbnailAnalogs of fexaramine and methods of making and using
Embodiments of a method of making the same, and of a composition comprising them are disclosed herein. Also disclosed are embodiments of a method of treating or preventing a metabolic disorder in a subject, comprising administering to a subject (e.g., via the gastrointestinal tract) a therapeutically effective amount of one or more of the disclosed compounds, thereby activating fxr receptors in the intestines, and treating or preventing a metabolic disorder in the subject.

 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof patent thumbnailCompositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
The present invention provides novel compositions for the delivery of a hypnotic agent across the oral mucosa. In particular, the buffer system in the compositions of the present invention raises the ph of saliva to a ph greater than about 7.8, thereby facilitating the substantially complete conversion of the hypnotic agent from its ionized to its un-ionized form.
Paratek Pharmaceuticals, Inc.


 Electrotherapeutic systems, devices, and methods patent thumbnailElectrotherapeutic systems, devices, and methods
Electrotherapeutic systems, devices, and methods are described. In one embodiment, a portion of a hepatic branch of a vagus nerve in a liver is stimulated with a lead implanted in the liver.
Cook Medical Technologies Llc


 Lactobacillus-based  ecoli  inhibition patent thumbnailLactobacillus-based ecoli inhibition
A method of reducing growth of pathogenic bacteria in a gastrointestinal tract of an animal by providing to the animal a composition having 1×1013 cfu of lactobacillus probiotic microorganisms per kilogram of feed. When 1×104 viable cells of the lactobacillus probiotic are added to 1×104 viable cells of escherichia coli in a solution of mrs broth in a test tube and incubated in a water bath at 37° c.
Microbios, Inc.


Tannin-containing gastrointestinal formulations and methods of use

Tannin-containing compositions and methods of using same to enhance or maintain immune function during simplified nutrition feeding. Pharmaceutical compositions, including enteral nutrition compositions, are provided.
Wisconsin Alumni Research Foundation

Apparatus and detecting gastrointestinal motor activity during post-operative recovery

System and methods for acquiring and processing myoelectrical data from the gastrointestinal tract of a patient are provided. In various embodiments, the systems and methods monitor the motor activity of a patient recovering from surgery to detect a resumption in gastrointestinal motility.
G-tech Medical, Inc.

System for marking a location for treatment within the gastrointestinal tract

A device and method for mapping, diagnosing and treating the intestinal tract is provided using a capsule passing through the intestinal tract. Further, a capsule tracking system is provided for tracking a capsule's location along the length of an intestinal tract as various treatment and/or sensing modalities are employed.
Entrack, Inc.

Method and buoyant gastric implant

A buoyant, expandable intragastric device is provided that can be inserted into the stomach of a patient. The device is inflated, or expanded, with gas or other low density material to partially fill the stomach and enabling the device, or implant, to be buoyant within the stomach by floating toward the highest location possible relative to the contents of the stomach and the configuration of the stomach walls.
Endobese, Inc.

Compositions and methods for treating inflammation-associated disorders of the gastrointestinal tract

The composition is administered to the subject following a therapeutically effective regimen, for length of time resulting in an improvement in one or more symptoms associated with inflammatory disorders of the gi tract.. .

Regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract

The present invention relates to a composition comprising an isolated cd4+ treg cell population, wherein the treg cells have signatures for i) identifying that the t-cells are cd4+ regulatory tcells, ii) identifying that the treg cells are tissue type tropic, i.e they can migrate to the diseased tissue, iii) optionally identifying that the treg cells are tropic with respect to the diseased tissue, i.e. They are homing cells, iv) identifying that the treg cells are emigrant cells, i.e.
Genovie Ab

Food matrices and methods of making and using

A method of these teachings for designing foods in order to improve the bioavailability of orally administered bioactive agents, the method including designing a food matrix, the food matrix not having bioactivity above its normal nutritional function, that increases bioavailability of a predetermined pharmaceutical or nutraceutical by at least one of facilitating the release and solubilization of bioactive agents in the predetermined pharmaceutical or nutraceutical, altering the absorption of lipophilic bioactive agents in the predetermined pharmaceutical or nutraceutical when co-ingested, or interfering with chemical transformations that occur within gastrointestinal tract (git) or after absorption; the food matrix being co-ingested with the predetermined pharmaceutical or nutraceutical or ingested at a specified time soon before or after the pharmaceutical or nutraceutical.. .
University Of Massachusetts

Support device for gastrointestinal implant

The present disclosure provides a support device for a gastrointestinal implant. The support device may include a lumen configured to extend through a submucosal tunnel and a mouth located at a proximal end of the lumen and in fluid communication with the lumen.
Cook Medical Technologies Llc

Method for diagnosis and treatment of disorders of the gastrointestinal tract, and use therewith

A method for diagnosing motility disorders of a gastrointestinal tract of a body. The method can include measuring electrical signals from the gastrointestinal tract while the patient is engaged in normal daily activities, recording the measured electrical signals on a portable electronic device carried by the body, recording by the patient in real time one or more symptoms of the body and analyzing characteristics of the recorded electrical signals with the recorded symptoms of the body to diagnosis gastrointestinal disorders of the body.
G-tech Medical, Inc.

Methods of treatment of c. difficile spores with ramoplanin

The present disclosure relates generally to methods of treatment of clostridium difficile-associated disorders and/or c. Difficile spores in the gastrointestinal tract by administering ramoplanin or a pharmaceutical formulation thereof, pharmaceutical compositions comprising ramoplanin, and therapeutic uses thereof in treating clostridium difficile-associated disorders and/or c.
Nanotherapeutics, Inc.

Gastrointestinal tract bypass devices

Devices and methods can be used for the endoscopic treatment of conditions such as obesity and metabolic diseases. For example, this document provides devices and methods for bypassing portions of the gastrointestinal tract to reduce nutritional uptake.
Mayo Foundation For Medical Educationand Research

Method for bowel preparation

The present invention provides methods for facilitating cleansing of the gastrointestinal tract of a patient prior to a diagnostic, surgical or therapeutic procedure. The methods can improve patient compliance, and thus, efficacy of the preparation.
Msm Innovations, Inc.

Composition for prevention and/or treatment of chronic inflammation and concomitant biofilms in the gastrointestinal tract

A pharmaceutical or neutraceutical composition for preventing or treating of chronic inflammation and concomitant biofilms in the gastrointestinal tract (gi tract). The multidimensional clinically tested composition accelerates intestinal epithelium recovery and it destabilises gram-negative bacteria in their habitat, but it also eliminates their lps molecules, which are highly allergenic.
Biotechnobel Sa

Method and gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation

Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include roux-en-y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy.
Covidien Lp

Compositions and methods for treating gastrointestinal disorders for humans and animal husbandry

Compositions containing hemicelluloses, citric acid and glucose syrup, fructose or sucrose in combination with polyphenols and prebiotics, methods of preparing the compositions, and methods of treating humans or animals with the composition are provided. Also provided is a method for increasing growth rate, improving feed efficiency and decreasing scour after weaning in an animal by administering an effective amount of the composition to the animal.

Oral virus vaccine

The present disclosure relates to a polymer-coated virus particle for an oral virus vaccine, a method of preparing the same, and a composition comprising the same. In accordance with the present disclosure, the oral virus vaccine can be effectively delivered to the intestines without being destroyed even in the low ph environment of the gastrointestinal tract, then the prevention efficacy against viral infections can be improved..
University-industry Foundation, Yonsei University

Mucin derived polypeptides

The present technology relates to isolated muc17, muc3 or muc3 derived polypeptides and polynucleotides encoding the same. The muc17, muc3 or muc3 derived polypeptides and polynucleotides can be used to treat gastrointestinal tract diseases and disorders.
Mucimed, Inc.

Compositions useful for the treatment of gastrointestinal disorders

This invention provides novel peptides and methods to prevent, control, and treat an inflammation, cancer and other disorders, particularly of the gastrointestinal tract and the lung by administering at least one agonist of guanalyte cyclase receptor either alone or in combination with a compound selected from i) 5-aminosalicyclic acid (5-asa) or a derivative or a pharmaceutically acceptable salt thereof; ii) mercaptopurine; or iii) an anti-tnf therapy.. .
Synergy Pharmaceuticals, Inc.

Fxr agonists and methods for making and using

Novel fxr agonists are disclosed, embodiments of a method of making the same, and of a composition comprising them are disclosed herein. Also disclosed are embodiments of a method of treating or preventing a metabolic disorder in a subject, comprising administering to a subject (e.g., via the gastrointestinal tract) a therapeutically effective amount of one or more of the disclosed compounds, thereby activating fxr receptors in the intestines, and treating or preventing a metabolic disorder in the subject.
The University Of Sydney

Probiotic recolonisation therapy

The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of bacteroides, eubacteria, fusobacteria, propionibacteria, lactobacilli, anaerobic cocci, ruminococcus, e.
Crestovo Llc

Probiotic recolonisation therapy

The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of bacteroides, eubacteria, fusobacteria, propionibacteria, lactobacilli, anaerobic cocci, ruminococcus, e.
Crestovo Llc

Probiotic recolonisation therapy

The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of bacteroides, eubacteria, fusobacteria, propionibacteria, lactobacilli, anaerobic cocci, ruminococcus, e.
Crestovo Llc

Microporous zirconium silicate for the treatment of hyperkalemia

The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. Potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects.
Zs Pharma, Inc.

Microporous zirconium silicate for the treatment of hyperkalemia

The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. Potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects.
Zs Pharma, Inc.

Suction stent, stent system, and sealing a leakage

A suction stent for introduction into a hollow organ of the human or animal body, preferably into the gastrointestinal tract, in particular the intestine, includes a tubular hollow body which is open in the longitudinal direction and made of biocompatible material. The tubular hollow body has a fixed diameter at least in its central portion.
Vac Stent Medtec Ag

Beta-lactamases with improved properties for therapy

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (gi tract) disorders such as c. Difficile infection (cdi)..
Synthetic Biologics, Inc.

Methods and compositions for using cinnamaldehyde and zinc for weight management

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical.
Nestec S.a.

Oral dosage forms for delivery of therapeutic agents

Oral dosage forms for the delivery of therapeutic agents include mechanical fasteners for engaging tissue of the gastrointestinal tract.. .
Covidien Lp

Sustained release formulation

The present invention is a sustained release formulation which is capable of controlling dissolution of a drug and of enduring peristaltic movement of the gastrointestinal tract. Specifically, the present invention is: a solid dosage form comprising a drug, croscarmellose sodium, an alkali metal salt or an alkoxide, and an alkali agent, wherein the alkali metal salt is a sodium salt or a potassium salt, and the alkali agent is a magnesium oxide; or a solid dosage form comprising a drug, croscarmellose sodium, an alkali metal salt or an alkoxide, and a water soluble polymer or a hydrophobic base, wherein the alkali metal salt is a sodium salt or a potassium salt..
Shionogi & Co., Ltd.

Systems, devices, and methods for forming anastomoses

The invention relates to deployable magnetic compression devices and systems and methods for the deployment of such magnetic compression devices. The magnetic compression devices are particularly useful for creating anastomoses, e.g., in the gastrointestinal tract.
Gi Windows, Inc.

Bacterial compositions and methods of use thereof for treatment of immune system disorders

Provided are compositions containing combinations of bacteria useful for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract, or other niche of a mammalian subject, and methods for use thereof, in particular for the treatment, inhibition, or prevention of immune disorders such as allergies and asthma.. .
Seres Therapeutics, Inc.

Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof

Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations..
Pronutria, Inc.

Handle and cable assemblies for electrosurgical devices and cyst ablation techniques

An electrosurgical medical device may include an elongate needle that is delivered to a gastrointestinal tract of a patient and inserted through the gastrointestinal wall and into a cyst. Fluid within the cyst may be aspirated through a lumen of the needle.
Cook Medical Technologies Llc

Engineered genetic enteric sensor bacteria and uses thereof

The disclosure relates to genetic engineered bacteria having a genetic memory circuit, compositions thereof, formulations thereof, methods of analyses and method of treatment of conditions related to the gastrointestinal tract including the mouth and the stomach.. .
President And Fellows Of Harvard College

Formulations

The present invention relates to a formulation comprising a pharmaceutically active ingredient and a coating. The invention also relates to the use of the formulation in the treatment and prevention of disorders of the gastrointestinal tract.
Sigmoid Pharma Limited

Use of a sweet whey containing infant formula for promoting the postnatal neuronal development of the infant gastrointestinal tract, and the establishment of the intestinal functions that it controls

The present invention relates to administration of sweet whey protein (swp) for promoting the enteric neuronal development in infants, especially preterm, low birth, very low and extremely low birth weight infants as well as in young children up until the age of six. Administration of the swp according to the invention prevents and treats disorders associated with an immature or impaired enteric nervous system.
Nestec S.a.

Controlled release and taste masking oral pharmaceutical composition

Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. A structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices.
Cosmo Technologies Limited

Beta-lactamases with improved properties for therapy

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (gi tract) disorders such as c. Difficile infection (cdi)..
Synthetic Biologics, Inc.

Methods and compositions for increasing energy expenditure using cinnamaldehyde

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical.
Nestec S.a.

Formulations for beneficially altering the microbiome

Several embodiments of the invention provide a unique system of formulations adapted to beneficially alter the microbiome. In one embodiment, the invention comprises four oral formulations designed to work synergistically to assist in weight management.
Vitamedica Corporation

Methods and apparatuses for orogastric decompression

A neonatal orogastric decompression device that allows simultaneous air flow and moisture absorbency. The neonatal orogastric decompression device prevents accumulation of air in the stomach and offers a more sanitary and efficient tool for health care professionals.



Gastrointestinal Tract topics:
  • Gastrointestinal
  • Gastrointestinal Tract
  • Galactooligosaccharide
  • Protein Source
  • Polysaccharides
  • Compatibility
  • Gastric Bypass
  • C Syndrome
  • Oral Formulation
  • Type 2 Diabetes
  • Gastrointestinal Disorders
  • Insulin Resistance
  • Blood Glucose
  • Fatty Liver
  • Metabolic Syndrome


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Gastrointestinal Tract for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gastrointestinal Tract with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.3998

    file did exist - 2955

    1 - 1 - 51